Detalhe da pesquisa
1.
Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction.
Braz J Infect Dis
; 27(3): 102757, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809850
2.
Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction
Braz. j. infect. dis
; 27(3): 102757, 2023. tab
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1447675